Skip to main content
Premium Trial:

Request an Annual Quote

Jai Nagarkatti, David Harvey, Lee McCollum, Avi Nash, Steven Paul, Pedro Reinhard, Timothy Sear, Dean Spatz, Barrett Toan, Rebecca Bergman, William O’Neill, Mimi Torrington, David Norwood, Riccardo Pigliucci, Trevor Nicholls, Hagan Bayley

Premium
Sigma-Aldrich has re-elected several members of its board of directors, including CEO Jai Nagarkatti, Chairman David Harvey, Lee McCollum, Avi Nash, Steven Paul, Pedro Reinhard, Timothy Sear, Dean Spatz, and Barrett Toan. The company also elected Rebecca Bergman to the board, and said that William O’Neill retired after being a director for 21 years.
 

 
Luminex has hired Mimi Torrington as director of investor relations, a company official said during the firm’s first-quarter conference call this week.
 

 
David Norwood, Riccardo Pigliucci, Trevor Nicholls, and Hagan Bayley have been appointed to the board of nanopore sequencing company Oxford Nanolabs, BioArray News sister publication In Sequence reported this week.
 
Bayley is a company founder and a professor of chemistry at the University of Oxford. Norwood, who chairs the board, is director of special projects at IP Group, one of the company’s investors. Pigliucci is a former president and chief operating officer of Perkin-Elmer, which is now Applera. Nicholls is a former chief commercial officer of Affymetrix and the former commercial director of the life science business of Amersham International, now part of GE Healthcare.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.